Tedd Van Buskirk is a shareholder in the firm's New York office and is a member of the Intellectual Property and Technology Litigation group.
Mr. Van Buskirk's practice focuses primarily on intellectual property litigation (at both the trial and appellate levels), including patent, trademark, trade secret, unfair competition and related antitrust issues, with an emphasis on pharmaceuticals and medical devices. Over the course of his career, Mr. Van Buskirk's practice has encompassed a variety of technologies, including medical devices, pharmaceuticals, foods, chemicals, biotechnology, consumer products, toys, telecommunications, computer hardware and software, and electronics. He has appeared in courts across the country in all phases of litigation from filing through trial.
Mr. Van Buskirk has litigated and arbitrated dozens of patent cases involving both branded and generic drugs, active pharmaceutical ingredients, food ingredients and supplements, enzymes, gastric bands, breast implants, tissue expanders, livestock technology, and consumer products, among others. He has significant experience counseling clients in and litigating ANDA cases arising out of the complex intersection of the patent and FDA laws relating to the Hatch-Waxman amendments to the Federal Food, Drug & Cosmetic Act.
In addition to his litigation practice, Mr. Van Buskirk is a registered patent attorney who prepares and prosecutes patent and trademark applications and handles patents interferences, post grant proceedings and trademark oppositions. He also delivers opinions on the scope, validity and enforceability of patents, and counsels established and emerging companies, venture capital and private equity firms, and underwriters in intellectual property licensing and transactional matters.
